Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Pericarditis Companies

ID: MRFR/Pharma/1315-CR
156 Pages
Nidhi Mandole
Last Updated: February 16, 2025
Pericarditis is a medical condition characterized by inflammation of the pericardium, the thin sac-like membrane surrounding the heart. This inflammation can lead to chest pain, fever, and other symptoms, making it a critical condition that requires prompt diagnosis and treatment.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Pericarditis Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)6.59%
2024 Market Size$ 3,267.13 Million
2025 Market Size$ 3,519.87 Million
2035 Market Size$ 6,621 Million
Key Players
Bristol-Myers Squibb
Novartis
Pfizer
AstraZeneca
Sanofi
Merck & Co.
Opportunities
  • Emerging Therapeutic Options
  • Rising Incidence of Pericarditis
  • Increased Awareness and Education

Top Industry Leaders in the Pericarditis Market

Pericarditis Key Companies
 
Latest Pericarditis Companies Update:

R-Pharm International LLC announces positive Phase IIb results for CardiolRx: This investigational new drug for recurrent pericarditis demonstrates potential for long-term disease control and reduced risk of recurrence.

Cardiol Therapeutics acquires PerImmune to advance development of CardiolRx: This acquisition strengthens CardiolRx's clinical development program and expands its focus on treating recurrent pericarditis.

Abbott Laboratories partners with Inovio Pharmaceuticals to develop DNA vaccine for pericarditis: This collaboration aims to prevent pericarditis associated with viral infections or autoimmune diseases.

List of Pericarditis Key companies in the market
  • Pfizer Inc.
  • AstraZeneca Plc
  • Novartis International AG
  • Allergan plc.
  • and Merck & Co., Inc.
  • Bayer AG
  • Reckitt Benckiser Group Plc.
  • PerkinElmer, Inc.
  • FUJIFILM Holdings Corporation
  • Sanofi
  • Johnson & Johnson Services